DelMar Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference on September 9, 2015 August 25, 2015 • 7:35 AM EDT
DelMar Pharmaceuticals to Present VAL-083 Lung Cancer Clinical Strategy at the 16th World Conference on Lung Cancer August 24, 2015 • 8:05 AM EDT
DelMar Pharmaceuticals Completes $2.6 Million Registered Direct Offering August 20, 2015 • 7:35 AM EDT
DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding from NRC-IRAP to Support Expanded Research Program with Lead Product Candidate VAL-083 August 17, 2015 • 8:05 AM EDT
DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering July 27, 2015 • 9:35 AM EDT
DelMar Pharmaceuticals Expands GBM Clinical Trial with Fifth Clinical Trial Site Added in Denver, Colorado July 20, 2015 • 7:35 AM EDT
DelMar Pharmaceuticals to Present Updated Phase I/II Clinical Data on VAL-083 in the Treatment of Refractory Glioblastoma Multiforme at GBM2015: 2nd International Symposium on Clinical and Basic Investigation in Glioblastoma July 9, 2015 • 7:35 AM EDT
DelMar Pharmaceuticals Invited to Present at The World NSCLC Summit on June 23-24, 2015 June 15, 2015 • 8:05 AM EDT
DelMar Pharmaceuticals to Present at the BIO International Convention on June 17, 2015 June 10, 2015 • 8:35 AM EDT
Del Mar Pharmaceuticals Inc. (DMPI) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10 June 4, 2015 • 8:00 AM EDT